Literature DB >> 24196572

The next generation of RAGE modulators: implications for soluble RAGE therapies in vascular inflammation.

Marion A Hofmann Bowman1, Ann Marie Schmidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24196572      PMCID： PMC3896235          DOI： 10.1007/s00109-013-1097-y

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  11 in total

Review 1.  The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

Review 2.  Atherosclerosis--an inflammatory disease.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

Review 3.  Alarmins: awaiting a clinical response.

Authors:  James K Chan; Johannes Roth; Joost J Oppenheim; Kevin J Tracey; Thomas Vogl; Marc Feldmann; Nicole Horwood; Jagdeep Nanchahal
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

4.  S100A12 expression in thoracic aortic aneurysm is associated with increased risk of dissection and perioperative complications.

Authors:  Deepanjana Das; Joseph Gawdzik; Lisa Dellefave-Castillo; Elizabeth M McNally; Aliya Husain; Jai Raman; Marion A Hofmann Bowman
Journal:  J Am Coll Cardiol       Date:  2012-07-18       Impact factor: 24.094

5.  Central role of RAGE-dependent neointimal expansion in arterial restenosis.

Authors:  Taichi Sakaguchi; Shi Fang Yan; Shi Du Yan; Dmitri Belov; Ling Ling Rong; Monica Sousa; Martin Andrassy; Steven P Marso; Stephan Duda; Bernd Arnold; Birgit Liliensiek; Peter P Nawroth; David M Stern; Ann Marie Schmidt; Yoshifumi Naka
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

6.  Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts.

Authors:  L Park; K G Raman; K J Lee; Y Lu; L J Ferran; W S Chow; D Stern; A M Schmidt
Journal:  Nat Med       Date:  1998-09       Impact factor: 53.440

7.  S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory program.

Authors:  Marion A Hofmann Bowman; Joseph Gawdzik; Usama Bukhari; Aliya N Husain; Peter T Toth; Gene Kim; Judy Earley; Elizabeth M McNally
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-10-21       Impact factor: 8.311

8.  Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice.

Authors:  Evis Harja; De-xiu Bu; Barry I Hudson; Jong Sun Chang; Xiaoping Shen; Kellie Hallam; Anastasia Z Kalea; Yan Lu; Rosa H Rosario; Sai Oruganti; Zana Nikolla; Dmitri Belov; Evanthia Lalla; Ravichandran Ramasamy; Shi Fang Yan; Ann Marie Schmidt
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

9.  Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis.

Authors:  Brendan M Everett; Aruna D Pradhan; Daniel H Solomon; Nina Paynter; Jean Macfadyen; Elaine Zaharris; Milan Gupta; Michael Clearfield; Peter Libby; Ahmed A K Hasan; Robert J Glynn; Paul M Ridker
Journal:  Am Heart J       Date:  2013-05-03       Impact factor: 4.749

10.  The N-glycoform of sRAGE is the key determinant for its therapeutic efficacy to attenuate injury-elicited arterial inflammation and neointimal growth.

Authors:  Hyun-Jin Tae; Ji Min Kim; Sungha Park; Noboru Tomiya; Geng Li; Wen Wei; Natalia Petrashevskaya; Ismayil Ahmet; John Pang; Stefanie Cruschwitz; Rebecca A Riebe; Yinghua Zhang; Christopher H Morrell; David Browe; Yuan Chuan Lee; Rui-ping Xiao; Mark I Talan; Edward G Lakatta; Li Lin
Journal:  J Mol Med (Berl)       Date:  2013-10-17       Impact factor: 4.599
View more
  6 in total

Review 1.  S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets.

Authors:  Adam Oesterle; Marion A Hofmann Bowman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-29       Impact factor: 8.311

Review 2.  The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality.

Authors:  Jyotiska Chaudhuri; Yasmin Bains; Sanjib Guha; Arnold Kahn; David Hall; Neelanjan Bose; Alejandro Gugliucci; Pankaj Kapahi
Journal:  Cell Metab       Date:  2018-09-04       Impact factor: 27.287

3.  Vessel ultrasound sonographic assessment of soluble receptor for advanced glycation end products efficacy in a rat balloon injury model.

Authors:  Hyun-Jin Tae; Natalia Petrashevskaya; Ismayil Ahmet; Sungha Park; Mark I Talan; Edward G Lakatta; Li Lin
Journal:  Curr Ther Res Clin Exp       Date:  2014-11-11

4.  Ischemia-reperfusion injury of the retina is linked to necroptosis via the ERK1/2-RIP3 pathway.

Authors:  Sheng Gao; Kalina Andreeva; Nigel G F Cooper
Journal:  Mol Vis       Date:  2014-09-24       Impact factor: 2.367

Review 5.  Medial vascular calcification revisited: review and perspectives.

Authors:  Peter Lanzer; Manfred Boehm; Victor Sorribas; Marc Thiriet; Jan Janzen; Thomas Zeller; Cynthia St Hilaire; Catherine Shanahan
Journal:  Eur Heart J       Date:  2014-04-16       Impact factor: 29.983

6.  Soluble Receptor for Advanced Glycation End Product Ameliorates Chronic Intermittent Hypoxia Induced Renal Injury, Inflammation, and Apoptosis via P38/JNK Signaling Pathways.

Authors:  Xu Wu; Wenyu Gu; Huan Lu; Chengying Liu; Biyun Yu; Hui Xu; Yaodong Tang; Shanqun Li; Jian Zhou; Chuan Shao
Journal:  Oxid Med Cell Longev       Date:  2016-09-05       Impact factor: 6.543
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.